Title
Category
Credits
Event date
Cost
- Free-to-Member
- Rapid Clinical Updates
- 1.00 ABIM MOC Self Evaluation Points
- 1.00 CME - AMA PRA Category 1 Credit™
- 1.00 Non-physician
$95.00
This session is presented by Marci Laudenslager, MD, MHS, DABOM and Lily Ackermann, MD, ScM, FHM. Our moderator is Ebrahim Barkoudah, MD, FACP, MPH, SFHM.
Obesity is projected to affect more than 50% of Americans by 2030 though, despite this epidemic, obesity remains chronically undertreated. Highly effective anti-obesity medications (e.g. GLP-1 receptor agonists) have revolutionized the landscape of obesity treatment and have the potential to close the obesity care gap. Participants will learn evidence-based obesity care strategies relevant for the hospitalized patient including how to manage GLP-1 receptor agonists. We will additionally discuss the broader societal impact of GLP-1s and review practical strategies to reduce weight bias and stigma in healthcare systems.